Exploration of Metabolite Biomarkers to Predict the Efficacy of Dupilumab Treatment for Atopic Dermatitis.
Autorzy:
Miyamoto S; Department of Dermatology, Hyogo Medical University, 1-1, Mukogawa-cho, Nishinomiya, Hyogo 663-8501, Japan.; Department of Dermatology Institute of Biomedical Sciences, Tokushima University Graduate School, 2-50-1, Kuramoto-cho, Tokushima, Tokushima 770-8503, Japan. Imai Y; Department of Dermatology, Hyogo Medical University, 1-1, Mukogawa-cho, Nishinomiya, Hyogo 663-8501, Japan.; Imai Adult and Pediatric Dermatology Clinic, 5-1-1, Ebie, Fukushima-ku, Osaka, Osaka 553-0001, Japan.; Department of Dermatology, Mie University Graduate School of Medicine, 2-174, Edobashi, Tsu, Mie 514-8507, Japan. MatsutaniM; Department of Dermatology, Hyogo Medical University, 1-1, Mukogawa-cho, Nishinomiya, Hyogo 663-8501, Japan. Nagai M; Department of Dermatology, Hyogo Medical University, 1-1, Mukogawa-cho, Nishinomiya, Hyogo 663-8501, Japan. Yamanishi K; Department of Dermatology, Hyogo Medical University, 1-1, Mukogawa-cho, Nishinomiya, Hyogo 663-8501, Japan.; Department of Dermatology, Mie University Graduate School of Medicine, 2-174, Edobashi, Tsu, Mie 514-8507, Japan. Kanazawa N; Department of Dermatology, Hyogo Medical University, 1-1, Mukogawa-cho, Nishinomiya, Hyogo 663-8501, Japan. Nishiumi S; Department of Omics Medicine, Hyogo Medical University, 1-1, Mukogawa-cho, Nishinomiya, Hyogo 663-8501, Japan.; Department of Biosphere Sciences, School of Human Sciences, Kobe College, 4-1, Okadayama, Nishinomiya, Hyogo 662-8505, Japan.
Pokaż więcej
Źródło:
Disease markers [Dis Markers] 2023 Nov 01; Vol. 2023, pp. 9013756. Date of Electronic Publication: 2023 Nov 01 (Print Publication: 2023).
TFIID dependency of steady-state mRNA transcription altered epigenetically by simultaneous functional loss of Taf1 and Spt3 is Hsp104-dependent.
Autorzy:
Iwami R; Molecular and Cellular Biology Laboratory, Graduate School of Medical Life Science, Yokohama City University, Yokohama, Kanagawa, Japan. Takai N; Molecular and Cellular Biology Laboratory, Graduate School of Medical Life Science, Yokohama City University, Yokohama, Kanagawa, Japan. MatsutaniM; NODAI Genome Research Center, Tokyo University of Agriculture, Setagaya-ku, Tokyo, Japan. Shiwa Y; NODAI Genome Research Center, Tokyo University of Agriculture, Setagaya-ku, Tokyo, Japan.; Department of Molecular Microbiology, Faculty of Life Sciences, Tokyo University of Agriculture, Setagaya-ku, Tokyo, Japan. Kokubo H; Faculty of Medicine, The University of Tokyo, Bunkyo-ku, Tokyo, Japan. Kasahara K; Department of Molecular Microbiology, Faculty of Life Sciences, Tokyo University of Agriculture, Setagaya-ku, Tokyo, Japan. Kokubo T; Molecular and Cellular Biology Laboratory, Graduate School of Medical Life Science, Yokohama City University, Yokohama, Kanagawa, Japan.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2023 Feb 09; Vol. 18 (2), pp. e0281233. Date of Electronic Publication: 2023 Feb 09 (Print Publication: 2023).
Bevacizumab beyond Progression for Newly Diagnosed Glioblastoma (BIOMARK): Phase II Safety, Efficacy and Biomarker Study.
Autorzy:
Nagane M; Department of Neurosurgery, Kyorin University Faculty of Medicine, Tokyo 181-8611, Japan. Ichimura K; Department of Brain Disease Translational Research, Juntendo University Graduate School of Medicine, Tokyo 113-8421, Japan. Onuki R; Division of Bioinformatics, National Cancer Center Research Institute, Tokyo 104-0045, Japan. Narushima D; Division of Bioinformatics, National Cancer Center Research Institute, Tokyo 104-0045, Japan. Honda-Kitahara M; Division of Brain Tumor Translational Research, National Cancer Center Research Institute, Tokyo 104-0045, Japan. Satomi K; Department of Diagnostic Pathology, National Cancer Center Hospital, Tokyo 104-0045, Japan. Tomiyama A; Department of Brain Disease Translational Research, Juntendo University Faculty of Medicine, Tokyo 113-8421, Japan. Arai Y; Division of Cancer Genomics, National Cancer Center Research Institute, Tokyo 104-0045, Japan. Shibata T; Division of Cancer Genomics, National Cancer Center Research Institute, Tokyo 104-0045, Japan. Narita Y; Department of Neurosurgery and Neuro-Oncology, National Cancer Center Hospital, Tokyo 104-0045, Japan. Uzuka T; Department of Neurosurgery, Dokkyo Medical University, Tochigi 321-0293, Japan. Nakamura H; Department of Neurosurgery, Faculty of Life Sciences, Kumamoto University, Kumamoto 860-8555, Japan. Nakada M; Department of Neurosurgery, Graduate School of Medical Sciences, Kanazawa University, Kanazawa 920-1192, Japan. Arakawa Y; Department of Neurosurgery, Graduate School of Medicine, Kyoto University, Kyoto 606-8501, Japan. Ohnishi T; Department of Neurosurgery, Graduate School of Medicine, Ehime University, Ehime 790-0052, Japan. Mukasa A; Department of Neurosurgery, Graduate School of Medicine, The University of Tokyo, Tokyo 113-8654, Japan. Tanaka S; Department of Neurosurgery, Graduate School of Medicine, The University of Tokyo, Tokyo 113-8654, Japan. Wakabayashi T; Department of Neurosurgery, Graduate School of Medicine, Nagoya University, Aichi 464-8601, Japan. Aoki T; Department of Neurosurgery, Kyoto Medical Center, Kyoto 612-8555, Japan. Aoki S; Department of Radiology, Graduate School of Medicine, Juntendo University, Tokyo 113-8421, Japan. Shibui S; Department of Neurosurgery, Teikyo University Hospital, Kawasaki 213-8507, Japan. MatsutaniM; Department of Neurosurgery, Kurosawa Hospital, Gunma 370-1203, Japan. Ishizawa K; Department of Pathology, Saitama Medical University, Saitama 350-0495, Japan. Yokoo H; Department of Human Pathology, Graduate School of Medicine, Gunma University, Gunma 371-8511, Japan. Suzuki H; Department of Pathology and Laboratory Medicine, National Hospital Organization Sendai Medical Center, Miyagi 983-8520, Japan. Morita S; Department of Biomedical Statistics and Bioinformatics, Graduate School of Medicine, Kyoto University, Kyoto 606-8501, Japan. Kato M; Division of Bioinformatics, National Cancer Center Research Institute, Tokyo 104-0045, Japan. Nishikawa R; Department of Neuro-Oncology/Neurosurgery, Saitama Medical University International Medical Center, Saitama 350-1298, Japan.
Pokaż więcej
Źródło:
Cancers [Cancers (Basel)] 2022 Nov 10; Vol. 14 (22). Date of Electronic Publication: 2022 Nov 10.
Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies